These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1991822)

  • 1. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.
    Xiao BG; Linington C; Link H
    J Neuroimmunol; 1991 Feb; 31(2):91-6. PubMed ID: 1991822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients.
    Markovic M; Trajkovic V; Drulovic J; Mesaros S; Stojsavljevic N; Dujmovic I; Mostarica Stojkovic M
    J Neurol Sci; 2003 Jul; 211(1-2):67-73. PubMed ID: 12767500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis.
    Karni A; Bakimer-Kleiner R; Abramsky O; Ben-Nun A
    Arch Neurol; 1999 Mar; 56(3):311-5. PubMed ID: 10190821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis.
    Kennel De March A; De Bouwerie M; Kolopp-Sarda MN; Faure GC; Béné MC; Bernard CC
    J Neuroimmunol; 2003 Feb; 135(1-2):117-25. PubMed ID: 12576231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.
    Klawiter EC; Piccio L; Lyons JA; Mikesell R; O'Connor KC; Cross AH
    Arch Neurol; 2010 Sep; 67(9):1102-8. PubMed ID: 20837855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between anti-myelin oligodendrocyte glycoprotein antibodies and serum/cerebrospinal fluid levels of the soluble interleukin-6 receptor complex in multiple sclerosis.
    Padberg F; Haase CG; Feneberg W; Schwarz MJ; Hampel H
    Neurosci Lett; 2001 Jun; 305(1):13-6. PubMed ID: 11356296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.
    Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P
    J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
    Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis.
    Guggenmos J; Schubart AS; Ogg S; Andersson M; Olsson T; Mather IH; Linington C
    J Immunol; 2004 Jan; 172(1):661-8. PubMed ID: 14688379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
    Wajgt A; Górny M
    Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
    Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
    Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations.
    Pittock SJ; Reindl M; Achenbach S; Berger T; Bruck W; Konig F; Morales Y; Lassmann H; Bryant S; Moore SB; Keegan BM; Lucchinetti CF
    Mult Scler; 2007 Jan; 13(1):7-16. PubMed ID: 17294606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid.
    Baig S; Olsson T; Yu-Ping J; Höjeberg B; Cruz M; Link H
    Scand J Immunol; 1991 Jan; 33(1):73-9. PubMed ID: 1705050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls.
    Onoue H; Satoh JI; Ogawa M; Tabunoki H; Yamamura T
    Acta Neurol Scand; 2007 Mar; 115(3):153-60. PubMed ID: 17295709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
    Egg R; Reindl M; Deisenhammer F; Linington C; Berger T
    Mult Scler; 2001 Oct; 7(5):285-9. PubMed ID: 11724443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.
    Kuhle J; Lindberg RL; Regeniter A; Mehling M; Hoffmann F; Reindl M; Berger T; Radue EW; Leppert D; Kappos L
    J Neurol; 2007 Feb; 254(2):160-8. PubMed ID: 17334662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.